Enterochromaffin-like cell

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

(Redirected from Enterochromaffine-like cell)
Jump to: navigation, search

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

WikiDoc Resources for

Enterochromaffin-like cell

Articles

Most recent articles on Enterochromaffin-like cell

Most cited articles on Enterochromaffin-like cell

Review articles on Enterochromaffin-like cell

Articles on Enterochromaffin-like cell in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Enterochromaffin-like cell

Images of Enterochromaffin-like cell

Photos of Enterochromaffin-like cell

Podcasts & MP3s on Enterochromaffin-like cell

Videos on Enterochromaffin-like cell

Evidence Based Medicine

Cochrane Collaboration on Enterochromaffin-like cell

Bandolier on Enterochromaffin-like cell

TRIP on Enterochromaffin-like cell

Clinical Trials

Ongoing Trials on Enterochromaffin-like cell at Clinical Trials.gov

Trial results on Enterochromaffin-like cell

Clinical Trials on Enterochromaffin-like cell at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Enterochromaffin-like cell

NICE Guidance on Enterochromaffin-like cell

NHS PRODIGY Guidance

FDA on Enterochromaffin-like cell

CDC on Enterochromaffin-like cell

Books

Books on Enterochromaffin-like cell

News

Enterochromaffin-like cell in the news

Be alerted to news on Enterochromaffin-like cell

News trends on Enterochromaffin-like cell

Commentary

Blogs on Enterochromaffin-like cell

Definitions

Definitions of Enterochromaffin-like cell

Patient Resources / Community

Patient resources on Enterochromaffin-like cell

Discussion groups on Enterochromaffin-like cell

Patient Handouts on Enterochromaffin-like cell

Directions to Hospitals Treating Enterochromaffin-like cell

Risk calculators and risk factors for Enterochromaffin-like cell

Healthcare Provider Resources

Symptoms of Enterochromaffin-like cell

Causes & Risk Factors for Enterochromaffin-like cell

Diagnostic studies for Enterochromaffin-like cell

Treatment of Enterochromaffin-like cell

Continuing Medical Education (CME)

CME Programs on Enterochromaffin-like cell

International

Enterochromaffin-like cell en Espanol

Enterochromaffin-like cell en Francais

Businness

Enterochromaffin-like cell in the Marketplace

Patents on Enterochromaffin-like cell

Experimental / Informatics

List of terms related to Enterochromaffin-like cell

Enterochromaffin-like cells or ECL cells are a type of neuroendocrine cells found in the gastric glands of the gastric mucosa beneath the epithelium, particularly in the vicinity of parietal cells. They are also considered a type of enteroendocrine cell.[1]




Function

Control of stomach acid secretions. ("ECL-cell" labeled at top center.)
Control of stomach acid secretions. ("ECL-cell" labeled at top center.)

ECL cells synthesize and secrete histamine being stimulated by the hormones gastrin, acetylcholine and pituitary adenylyl cyclase-activating peptide.

Gastrin is transferred from a specific type of G cell in the gastric epithelium to the ECL cells by blood. Histamine and gastrin act synergistically as the most important stimulators of hydrochloric acid secretion from parietal cells and stimulators of secretion of different pepsins from oxyntic cells.

Enterochromaffin-like cells also produce pancreastatin and probably other peptide hormones and growth factors.








Pathology

A prolonged stimulation of these cells causes their hyperplasia. This is especially important in gastrinoma (the tumors in which there is an excessive secretion of gastrin), as this is one of the factors contributing to Zollinger-Ellison's syndrome. It was once believed that tumors of ECL origin form after a prolonged inhibition of gastric acid secretion, however there is no data to support this conclusion and proton pump inhibitors are not thought to contribute to gastric cancer.

Name

The name is derived from their location in the enteric system and their chromaffin-like staining pattern in histologic sections, which is characterized by silver staining.

References


See also


WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch


Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

Personal tools